Discover how Jules Bordet's Nobel-winning research revolutionized immunology by uncovering the synergy between antibodies and ...

Fabhalta slowed eGFR decline by 48% vs placebo over two years, demonstrating kidney function preservation1 Clinically meaningful improvements of protein in urine observed as early as two weeks, with ...

Fabhalta slowed eGFR decline by 48% vs placebo over two years, demonstrating kidney function preservation1 Clinically meaningful improvements of protein in urine observed as early as two weeks, with s ...

Cemdisiran, a potential new drug for the treatment of generalized myasthenia gravis, has been accepted for priority review by ...

Eleven new molecular drug targets receive approval in 2025, expanding treatment options for rare diseases, cancer, and infectious diseases.

Regeneron's Phase III trial investigated cemdisiran and pozelimab as both monotherapies and in combination in gMG.

Consumer Action for a Strong Economy (CASE) urges the Trump administration to reject demands for tariffs on beef imports as ...

Europe's transition towards climate neutrality is taking place against an increasingly complex global backdrop, writes Atul ...

"There are many capable Korean companies that are willing to transfer global exclusive licensing rights and have data ...

Intermittent fasting is the practice of eating during specific time frames while reducing calorie intake or abstaining from ...

Discover the personal care habits that help promote healthy aging, maintain a fresh appearance, and preserve both physical ...

Jennifer Lopez, at 56 years old, maintains a youthful image thanks to her beauty habits, exercise routine, nutrition choices, ...